CDH1 and neoplasm: Consistently, the cytotoxicity of CD103+ tumor-infiltrating lymphocyte (TIL) toward autologous E-cadherin+ tumor cells is inhibited anti-CD103 blocking antibody (Le Floc'h et al., 2007).